NCT03184441

Brief Summary

This pilot project proposes to develop and test a new device to manage (defined as resolving, prohibiting, inhibiting or preventing) the development of Deformational Plagiocephaly (DP) in prematurely born infants weighing \< 1 kilogram.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 12, 2017

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

August 14, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

March 19, 2019

Status Verified

July 1, 2018

Enrollment Period

2 months

First QC Date

April 28, 2017

Results QC Date

January 23, 2018

Last Update Submit

March 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Safety of Use of the Premie Pouch in VLBW Infants

    Frequency of participants with adverse events reported using the Premie Pouch Adverse Event Data Collection Tool.

    From date of enrollment to date of study completion (range 19-47 days)

Secondary Outcomes (4)

  • Feasibility of Use of the Premie Pouch in VLBW Infants

    Number of hours per each 24 hour period on the device

  • Number of Participants With Normal Cranial Index

    Cranial index at study completion

  • Number of Participants With Normal Cranial Symmetry

    Cranial symmetry at study completion

  • Premie Pouch Ease of Use

    From date of enrollment to date of study completion (range 19-47 days)

Study Arms (1)

Premie Pouch

EXPERIMENTAL

All participants will receive the experimental treatment with the Premie Pouch device.

Device: Premie Pouch

Interventions

The Premie Pouch is an experimental device meant to manage the development of Deformational Plagiocephaly (DP) starting immediately following birth. The Premie Pouch has a concave-shaped foam insert that will provide a resting surface for the infant's head and body that will eliminate uneven pressure on the infant's occiput while maintaining correct body alignment. Also, the posterior neck area of the infant will be supported by a fixed bridge section of the foam insert. The Premie Pouch is designed specifically for the very low birth weight (VLBW) infant.

Premie Pouch

Eligibility Criteria

AgeUp to 40 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Infants weighing \</= 900 grams. (Selecting a weight below the 1 Kg cut off for using the device will allow the infant an opportunity to use the device before outgrowing it.)
  • Infants born at \>/= 22 weeks gestation.
  • Infants \</= 40 days of age at enrollment.
  • Infants that receive medical clearance from their healthcare team.
  • Infants that have an estimated minimum hospital length of stay = / \> 14 days from the time of enrollment.
  • Every effort will be made to include infants from non-English speaking families as long as using all available resources; the parents can successfully communicate with the research team. The research team will utilize interpreter services and other resources (immediate family members and supports) to facilitate this process when applicable.

You may not qualify if:

  • Infants that require only prone positioning to maintain airway patency (such as those with Pierre Robin Syndrome/Sequence) will not be eligible to participate; this is because infants must be able to lie supine for at least part of the day.
  • Infants requiring medical devices such as a continuous ventricular drain, subgaleal shunt, or intravenous catheters (unless placement of the IV is temporary) as they prevent proper positioning using the Premie Pouch.
  • Infants with a craniofacial anomaly, craniosynostosis, cervical anomaly, or critical airway.
  • Infants with Cutis Aplasia or significant skin breakdown to the scalp, because the experimental device may worsen a preexisting condition.
  • Infants that are to be transferred to a non-participating hospital within 14 days of enrollment as this timeframe may not allow adequate evaluation of the Premie Pouch.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Children's Hospital Boston

Boston, Massachusetts, 02115, United States

Location

St. Elizabeth's Medical Center

Brighton, Massachusetts, 02135, United States

Location

South Shore Hospital

Weymouth, Massachusetts, 02190, United States

Location

Related Publications (3)

  • Seruya M, Oh AK, Sauerhammer TM, Taylor JH, Rogers GF. Correction of deformational plagiocephaly in early infancy using the plagio cradle orthotic. J Craniofac Surg. 2013 Mar;24(2):376-9. doi: 10.1097/SCS.0b013e31828010d1.

    PMID: 23524697BACKGROUND
  • Rogers GF, Miller J, Mulliken JB. Comparison of a modifiable cranial cup versus repositioning and cervical stretching for the early correction of deformational posterior plagiocephaly. Plast Reconstr Surg. 2008 Mar;121(3):941-947. doi: 10.1097/01.prs.0000299938.00229.3e.

    PMID: 18317143BACKGROUND
  • DeGrazia M, Giambanco D, Hamn G, Ditzel A, Tucker L, Gauvreau K. Prevention of deformational plagiocephaly in hospitalized infants using a new orthotic device. J Obstet Gynecol Neonatal Nurs. 2015 Jan-Feb;44(1):28-41. doi: 10.1111/1552-6909.12523. Epub 2015 Jan 8.

    PMID: 25573141BACKGROUND

MeSH Terms

Conditions

Plagiocephaly

Condition Hierarchy (Ancestors)

Craniofacial AbnormalitiesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Michele DeGrazia
Organization
Boston Children's Hospital

Study Officials

  • Michele DeGrazia, PhD, NNP

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Nursing Research, Neonatal Intensive Care Unit

Study Record Dates

First Submitted

April 28, 2017

First Posted

June 12, 2017

Study Start

June 1, 2016

Primary Completion

August 1, 2016

Study Completion

March 1, 2019

Last Updated

March 19, 2019

Results First Posted

August 14, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations